Expert Opinion on Neurology

About this Collection

Cover image of Neurology collection

 

The Expert Opinion collections are online feeds that group together articles published from across the Expert Opinion series by therapy area. Articles from 2011 onwards are included.

 

Expert Opinion on Neurology covers the entire development pipeline of treatments for disorders affecting the nervous system; from drug-discovery techniques and therapeutic targets to animal models, clinical testing, and finally, evaluations of the efficacy and safety of launched therapies.

 












All Articles

Showing 1 to 20 of 387 Articles Left arrow
Previous page
Next page
Right arrow
Order results by:
Newest

Oldest

Most Read

Alert me when new articles are published in this collection

 

Selected Add to Favourites |
View Summaries |
Download Citation


1.
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

Michael Maes, George Anderson, Marta Kubera, Michael Berk

Expert Opinion on Therapeutic Targets May 2022, Vol. 18, No. 5, Pages 495-512
Summary | Full Text | PDF (599 KB) | PDF Plus (744 KB)
|
Add to Favourites
| Related 


2.
Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer’s disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

Yu Nakamura, Shin Kitamura, Akira Homma, Kazuhito Shiosakai, Daiju Matsui

Expert Opinion on Pharmacotherapy May 2022, Vol. 15, No. 7, Pages 913-925
Summary | Full Text | PDF (985 KB) | PDF Plus (1004 KB)
|
Add to Favourites
| Related 


3.
Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

Arianna Sartori, Dawn Carle, Mark S Freedman

Expert Opinion on Pharmacotherapy May 2022, Vol. 15, No. 7, Pages 1019-1027
Summary | Full Text | PDF (232 KB) | PDF Plus (267 KB)
|
Add to Favourites
| Related 


4.
Safinamide for the treatment of Parkinson’s disease

Livia Dézsi, László Vécsei

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 729-742
Summary | Full Text | PDF (313 KB) | PDF Plus (384 KB)
|
Add to Favourites
| Related 


5.
Pharmacotherapy for restless legs syndrome

Luigi Ferini-Strambi, Sara Marelli

Posted online on 19 Apr 2022.

Summary | Full Text | PDF (282 KB) | PDF Plus (284 KB)
|
Add to Favourites
| Related 


6.
Investigational approaches to therapies for restless legs syndrome

Stefano de Biase, Giovanni Merlino, Simone Lorenzut, Mariarosaria Valente, Gian Luigi Gigli

Posted online on 7 Apr 2022.

Summary | Full Text | PDF (239 KB) | PDF Plus (241 KB)
|
Add to Favourites
| Related 


7.
Investigational drugs in Alzheimer’s disease: current progress

Camryn Berk, Gaurav Paul, Marwan Sabbagh

Posted online on 5 Apr 2022.

Summary | Full Text | PDF (216 KB) | PDF Plus (218 KB)
|
Add to Favourites
| Related 


8.
Targeted treatments in fragile X syndrome

Emma B Hare, Randi J Hagerman, Reymundo Lozano

Posted online on 4 Apr 2022.

Summary | Full Text | PDF (571 KB) | PDF Plus (573 KB)
|
Add to Favourites
| Related 


9.
Current and future approaches for treatment of paraneoplastic neurological syndromes with well-characterized onconeural antibodies

Adriaan HC de Jongste, Joost van Rosmalen, Jan W Gratama, Peter AE Sillevis Smitt

Expert Opinion on Orphan Drugs May 2022, Vol. 2, No. 5, Pages 483-496
Summary | Full Text | PDF (492 KB) | PDF Plus (494 KB)
|
Add to Favourites
| Related 


10.
 The discovery and development of perampanel for the treatment of epilepsy

Takahisa Hanada

Expert Opinion on Drug Discovery Apr 2022, Vol. 9, No. 4, Pages 449-458
Summary | Full Text | PDF (252 KB) | PDF Plus (311 KB)
|
Add to Favourites
| Related 


11.
Current status and perspectives in the treatment of Prader-Willi syndrome

Corin Badiu, Otilia Mărginean

Expert Opinion on Orphan Drugs Apr 2022, Vol. 2, No. 4, Pages 337-347
Summary | Full Text | PDF (254 KB) | PDF Plus (256 KB)
|
Add to Favourites
| Related 


12.
Management of acute intermittent porphyria

Pauline Harper, Eliane Sardh

Expert Opinion on Orphan Drugs Apr 2022, Vol. 2, No. 4, Pages 349-368
Summary | Full Text | PDF (483 KB) | PDF Plus (490 KB)
|
Add to Favourites
| Related 


13.
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures

Valentina Franco, Alfonso Iudice, Elisabetta Grillo, Rita Citraro, Giovambattista De Sarro, Emilio Russo

Expert Opinion on Pharmacotherapy Apr 2022, Vol. 15, No. 5, Pages 637-644
Summary | Full Text | PDF (377 KB) | PDF Plus (379 KB)
|
Add to Favourites
| Related 


14.
Small molecule inhibitors in the treatment of cerebral ischemia

Jerry J Flores, Yang Zhang, Damon W Klebe, Tim Lekic, Weiling Fu, John H Zhang

Expert Opinion on Pharmacotherapy Apr 2022, Vol. 15, No. 5, Pages 659-680
Summary | Full Text | PDF (764 KB) | PDF Plus (766 KB)
|
Add to Favourites
| Related 


15.
Treating epilepsy in pregnant women

Mervyn J Eadie

Expert Opinion on Pharmacotherapy Apr 2022, Vol. 15, No. 6, Pages 841-850
Summary | Full Text | PDF (231 KB) | PDF Plus (296 KB)
|
Add to Favourites
| Related 


16.
Novel monoclonal antibodies for therapy of multiple sclerosis

Benjamin Knier, Bernhard Hemmer, Thomas Korn

Expert Opinion on Biological Therapy Apr 2022, Vol. 14, No. 4, Pages 503-513
Summary | Full Text | PDF (391 KB) | PDF Plus (393 KB)
|
Add to Favourites
| Related 


17.
Advances in stem-cell–generated transplantation therapy for Parkinson’s disease

Maria Sundberg, Ole Isacson

Expert Opinion on Biological Therapy Apr 2022, Vol. 14, No. 4, Pages 437-453
Summary | Full Text | PDF (418 KB) | PDF Plus (512 KB)
|
Add to Favourites
| Related 


18.
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis

Radu Tanasescu, Cris S Constantinescu

Expert Opinion on Drug Metabolism & Toxicology Apr 2022, Vol. 10, No. 4, Pages 621-630
Summary | Full Text | PDF (360 KB) | PDF Plus (445 KB)
|
Add to Favourites
| Related 


19.
Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration

Wolfgang H Jost

Expert Opinion on Drug Safety Apr 2022, Vol. 13, No. 4, Pages 447-458
Summary | Full Text | PDF (488 KB) | PDF Plus (555 KB)
|
Add to Favourites
| Related 


20.
Retinoid X receptor ligands: a patent review (2007 – 2013)

Shoya Yamada, Hiroki Kakuta

Expert Opinion on Therapeutic Patents Apr 2022, Vol. 24, No. 4, Pages 443-452
Summary | Full Text | PDF (424 KB) | PDF Plus (427 KB)
|
Add to Favourites
| Related 

Showing 1 to 20 of 387 Articles Left arrow
Previous page
Next page
Right arrow